ZBP1 pathway promotes tumor immunogenicity in the combination of anti-HER2 therapy and epigenetic therapy

Qishan Wang(Zhejiang University), Liufu Deng(Shanghai Jiao Tong University)
Cell Reports
September 17, 2025
Cited by 6


Related Papers